Sophia Bruggeman

Search results

• 2020

  Loss of H3K27 Methylation Identifies Poor Outcome in Adult-Onset Acute Myeloid Leukemia

  van Dijk, A. D., Hoff, F. W., Qiu, Y., de Bont, E. S., Bruggeman, S. W. M., Horton, T. M. & Kornblau, S. M., 5-Nov-2020, In: Blood. 136, 3 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

• Loss of H3K27 Methylation Identifies Poor Outcomes in Adult-Onset Acute Lymphoblastic and Myeloid Leukemia

  van Dijk, A., Hoff, F., Qiu, Y., Jabbour, E., de Bont, E., Bruggeman, S., Horton, T. & Kornblau, S., Sept-2020, In: Clinical lymphoma myeloma & leukemia. 20, p. S205-S206 2 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2019

  Prognostic Significance of FOXO3 in Pediatric Acute Myeloid Leukemia (AML) Patients Treated with Bortezomib Addition to Standard Therapy: Results from a Children's Oncology Group Phase 3 Clinical Trial

  van Dijk, A. D., Ruvolo, P. P., Hoff, F. W., Qiu, Y., Gamis, A. S., Aplenc, R., Kolb, A. E., Alonzo, T. A., Gerbing, R. B., de Bont, E. S., Bruggeman, S. W. M., Horton, T. M. & Kornblau, S. M., 13-Nov-2019, In: Blood. 134, 4 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

• The developmental stage of the medulloblastoma cell-of-origin is maintained in cancer and restricts hedgehog pathway usage and drug sensitivity

  Smit, M., Armandari, I., Bockaj, I., Martini, T., Zomerman, W., Siragna, Z., Meeuwsen-de Boer, T., Scherpen, F., Schoots, M., Ritsema, M., den Dunnen, W., Hoving, E., Paridaen, J., de Haan, G., Guryev, V. & Bruggeman, S., Apr-2019, In: Neuro-Oncology. 21, p. 104 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic
• 2018

  IDENTIFICATION OF TWO PROTEIN-SIGNALING STATES DELINEATING TRANSCRIPTIONALLY HETEROGENEOUS HUMAN MEDULLOBLASTOMA

  Zomerman, W., Plasschaert, S., Conroy, S., Scherpen, F., Meeuwsen-de Boer, T., Lourens, H.-J., Llobet, S. G., Smit, M., Slagter-Menkema, L., Seitz, A., Gidding, C., Hulleman, E., Wesseling, P., Meijer, L., van Kempen, L., van den Berg, A., Warmerdam, D., Kruyt, F., Foijer, F. & van Vugt, M. & 5 others, den Dunnen, W., Hoving, E., Guryev, V., de Bont, E. & Bruggeman, S., Jun-2018, In: Neuro-Oncology. 20, p. 136-136 1 p.

  Research output: Contribution to journal › Meeting Abstract › Academic

• RPPA-Profiling Identifies Patients with Low Phosphorylation Levels of HSF1 at Serine 326 As Potential Candidate for Bortezomib Treatment in Addition to Standard Therapy in Pediatric Acute Myeloid Leukemia

  Hoff, F. W., Hu, W., Qiu, Y., Gamis, A. S., Aplenc, R., Kolb, E. A., Alonzo, T. A., Qutub, A. A., de Bont, E. S., Bruggeman, S. W. M., Kornblau, S. M. & Horton, T. M., 29-Nov-2018, In: Blood. 132, Suppl.1, 3 p.

  Research output: Contribution to journal › Meeting Abstract › Academic